Paula Lorgelly is a Professor of Health Economics at the University of Auckland. After completing her PhD at Otago she spent 22 years abroad working in academia in the United Kingdom and Australia (including a visiting position in Germany), and the independent sector in the United Kingdom. Her research interests span three defined areas: the determinants of health and healthcare, economic evaluation and outcome measurement. She has worked across the health and medical spectrum and much of her clinical research has focused on cancer, particularly genomics and precision medicine, and more recently long COVID. Returning to Aotearoa New Zealand Paula hopes to build capacity in health economics, ensuring that it is recognised for the value it brings to decision making.

Robin is a health economist and current PhD student in clinical informatics/biostatistics. His work focuses on clinical prediction model development, validation and implementation in large datasets. He has been a health economist since 2016, with a research interest in simulation modelling, health policy, and statistical methods.

William Leung, MSc (Health Econ) MSc (Op Res) MSc (Comp Sci), is a senior lecturer in health economics at the University of Otago, Wellington, and consulting health economist at the Dunedin School of Medicine. Prior to receiving his master’s degree at York, he worked in the UK NHS and other government agencies as an analyst. Recent projects have included an economic evaluation funded by US CDC and an operational research study with MfE. 

Pasquale is a B.Pharm graduate of the Otago University School of Pharmacy and an MSc graduate from Auckland University. He spent nearly 3 years as a Science Advisor at Medsafe, the NZ regulatory authority, before joining Janssen Cilag in 1999. During his 23 years in the pharmaceutical industry, he has held functional responsibility for many departments including Regulatory Affairs, Quality, Pharmacovigilance, Medical Information, Business Development and Market Access. Pasquale is currently the Associate Medical Director for Pfizer in NZ.

Augusta is a graduate of the BHSc and BA (economics) programmes at the University of Auckland, and most recently completed an MSc in International Health Policy (Health Economics) at the London School of Economics. While in the UK, Augusta contributed to economic modelling and statistical analysis projects to support HTA submissions in a UK-based HEOR and market access consultancy. Augusta Connor is now a Senior Health Economist/Team Leader at Pharmac. She is passionate about distributive justice, and brings this to her role as a focus on process equity and decision making to address population health inequities.

Ross Wilson [BCom(Hons), PhD] is a research fellow at the Centre for Musculoskeletal Outcomes Research, University of Otago. His research interests are in the valuation of health-related quality of life (HRQoL), economic evaluation of healthcare interventions, and simulation modelling of disease epidemiology and treatment to inform health care policy.

Professor Carlo Marra [BSc (Pharm),PharmD, PhD] is Dean of the School of Pharmacy at the University of Otago. Professor Marra completed a PhD in health economics/health outcomes research at the University of British Columbia in 2004 but has been active in health economics research since 1995 as a research pharmacist at Vancouver General Hospital in Canada.  Professor Marra has published more than 250 peer-reviewed manuscripts and has presented at more than 150 international conferences.   Professor Marra’s research interests are economic evaluation of health care programmes and strategies, patient preferences, and choice experiments.   Professor Marra is an Associate Editor (Health Economics) for the journal Arthritis Care and Research.